Kandi Technologies Group, Inc. (KNDI)

Verve Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-50.5	0.01	-12.12	22.86	-10.39
Depreciation & Amortization	11.94	11.83	12.34	9.95	8.14
Other Amortization	0.08	0.08	0.09	0.09	0.09
Loss (Gain) From Sale of Assets	2.83	-	-	-48.4	-14.17
Asset Writedown & Restructuring Costs	45.5	1.44	3.34	-	-
Loss (Gain) From Sale of Investments	-0.42	0.14	-	-17.79	-
Loss (Gain) on Equity Investments	-	-	-	2.59	17.25
Stock-Based Compensation	7.11	11.06	1.93	1.48	0.9
Provision & Write-off of Bad Debts	0.88	0.66	-0.54	0.86	-0.15
Other Operating Activities	-9.29	0.06	-5.39	1.24	-4.78
Change in Accounts Receivable	-29.77	10.56	-20.97	-2.54	19.25
Change in Inventory	-12.68	-20.04	7.13	20.26	-27.08
Change in Accounts Payable	79.04	38.6	62.59	2.18	-30.99
Change in Income Taxes	-0.58	0.95	-0.03	0.15	-0.75
Change in Other Net Operating Assets	-61.98	-156.52	-16.9	7.3	-8.18
Operating Cash Flow	-17.82	-101.16	31.48	0.24	-50.88
Operating Cash Flow Growth	-	-	12924.55%	-	-
Capital Expenditures	-0.93	-13.25	-3.82	-16.79	-14.9
Sale of Property, Plant & Equipment	-	-	-	23.31	52.58
Cash Acquisitions	-	0.28	-	-7.12	-
Divestitures	-0.16	-	-	-	-
Sale (Purchase) of Intangibles	-	-	-	-2.36	-3.28
Investment in Securities	26.82	45.24	-31.21	-6.62	42.85
Investing Cash Flow	25.72	32.28	-35.03	22.21	51.15
Short-Term Debt Issued	66.2	23.42	30.77	0.95	24.64
Long-Term Debt Issued	-	8.23	-	2.21	0.39
Total Debt Issued	66.2	31.65	30.77	3.16	25.04
Short-Term Debt Repaid	-37.49	-19.71	-28.36	-	-50.87
Long-Term Debt Repaid	-2.28	-0.05	-	-	-28.8
Total Debt Repaid	-39.77	-19.76	-28.36	-	-79.67
Net Debt Issued (Repaid)	26.43	11.89	2.41	3.16	-54.64
Issuance of Common Stock	-	3.45	-	-	181.08
Repurchase of Common Stock	-3.92	-0.51	-7.5	-2.41	-
Other Financing Activities	-	-	0.76	-	-
Financing Cash Flow	22.51	14.83	-4.33	0.75	126.45
Foreign Exchange Rate Adjustments	-3.2	-3.36	-9.75	2.96	-0.71
Net Cash Flow	27.21	-57.41	-17.64	26.16	126.01
Free Cash Flow	-18.76	-114.41	27.66	-16.54	-65.79
Free Cash Flow Margin	-14.70%	-92.56%	23.48%	-18.08%	-85.52%
Free Cash Flow Per Share	-0.22	-1.43	0.37	-0.22	-1.18
Cash Interest Paid	1.74	0.97	0.35	0.04	0.65
Cash Income Tax Paid	0.86	0.31	0.35	2.07	1.05
Levered Free Cash Flow	-32.52	-118.47	10.08	-59.29	7.61
Unlevered Free Cash Flow	-31.15	-117.64	10.52	-59.03	9.95
Change in Net Working Capital	21.45	120.11	-15.2	22	-27.4

Updated Nov 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q